Mariam Mansour
Company: Prescient Therapeutics Pty Ltd
Job title: Senior Director Clinical development and Translational sciences
Seminars:
CellPryme Is a Novel Agent That Improves Cell Phenotype, Improves Tumor Control & Overcomes Immunosuppressive TME 3:00 pm
CellPryme is a small molecule with up to Phase II clinical experience A single exposure of CellPryme during CAR-T expansion significantly increases memory phenotype resulting in exhaustion resistant cells with improved persistence, tumor trafficking/penetrance, and tumor/cell killing Combining CellPryme with conventional CAR-T therapy increases CAR-T cell proliferation and overcomes the immunosuppressive tumor microenvironment to improve…Read more
day: Post-Conference Day - Tackling Solid Tumors
Panel Discussion: Combining Cell Therapies with Synergistic Treatments to Prevent Antigen Escape 2:30 pm
Uncovering combination assets to synergize cell therapies and potentiate anti-tumor response Mitigating against combinatorial toxicities to promote safe tumor regressionRead more
day: Post-Conference Day - Tackling Solid Tumors